<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37227147</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2165-0497</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>Microbiology spectrum</Title><ISOAbbreviation>Microbiol Spectr</ISOAbbreviation></Journal><ArticleTitle>Assessment of Enterovirus Antibodies during Early Childhood Using a Multiplex Immunoassay.</ArticleTitle><Pagination><StartPage>e0535222</StartPage><MedlinePgn>e0535222</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e05352-22</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/spectrum.05352-22</ELocationID><Abstract><AbstractText>Enteroviruses are a group of positive single-stranded viruses that belong to the Picornaviridae family. They regularly infect humans and cause symptoms ranging from the common cold and hand-foot-and-mouth disease to life-threatening conditions, such as dilated cardiomyopathy and poliomyelitis. Enteroviruses have also been associated with chronic immune-mediated diseases, such as type 1 diabetes, celiac disease, and asthma. Studying these disease-pathogen connections is challenging due to the high prevalence of enterovirus infections in the population and the transient appearance of the virus during the acute infection phase, which limit the identification of the causative agent via methods based on the virus genome. Serological assays can detect the antibodies induced by acute and past infections, which is useful when direct virus detection is not possible. We describe in this immuno-epidemiological study how the antibody levels against VP1 proteins from eight different enterovirus types, representing all seven of the human infecting enterovirus species, vary over time. VP1 responses first significantly (<i>P</i> &lt; 0.001) decline until 6 months of age, reflecting maternal antibodies, and they then start to increase as the infections accumulate and the immune system develops. All 58 children in this study were selected from the DiabImmnune cohort for having PCR-confirmed enterovirus infections. Additionally, we show that there is great, although not complete, cross-reactivity of VP1 proteins from different enteroviruses and that the response against 3C-pro could reasonably well reflect the recent Enterovirus infection history (ρ = 0.94, <i>P</i> = 0.017). The serological analysis of enterovirus antibodies in sera from children paves the way for the development of tools for monitoring the Enterovirus epidemics and associated diseases. <b>IMPORTANCE</b> Enteroviruses cause a wide variety of symptoms ranging from a mild rash and the common cold to paralyzing poliomyelitis. While enteroviruses are among the most common human pathogens, there is a need for new, affordable serological assays with which to study pathogen-disease connections in large cohorts, as enteroviruses have been linked to several chronic illnesses, such as type 1 diabetes mellitus and asthma exacerbations. However, proving causality remains an issue. In this study, we describe the use of an easily customizable multiplexed assay that is based on structural and nonstructural enterovirus proteins to study antibody responses in a cohort of 58 children from birth to 3 years of age. We demonstrate how declining maternal antibody levels can obscure the serological detection of enteroviruses before the age of six months and how antibody responses to nonstructural enterovirus proteins could be interesting targets for serodiagnosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jouppila</LastName><ForeName>N V V</ForeName><Initials>NVV</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehtonen</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seppälä</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puustinen</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oikarinen</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laitinen</LastName><ForeName>O H</ForeName><Initials>OH</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knip</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Tampere University Hospital, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyöty</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hytönen</LastName><ForeName>V P</ForeName><Initials>VP</Initials><Identifier Source="ORCID">0000-0002-9357-1480</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fimlab Laboratories, Tampere, Finland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Microbiol Spectr</MedlineTA><NlmUniqueID>101634614</NlmUniqueID><ISSNLinking>2165-0497</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003139" MajorTopicYN="Y">Common Cold</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007118" MajorTopicYN="N">Immunoassay</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antigen</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">diagnostics</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">humoral response</Keyword><Keyword MajorTopicYN="N">multiplex assay</Keyword><Keyword MajorTopicYN="N">serology</Keyword></KeywordList><CoiStatement>The authors declare a conflict of interest. H.H. and M.K. are shareholders and members of the board of Vactech Ltd. which develops vaccines against picornaviruses. The other authors have no conflict of interest to declare. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>25</Day><Hour>13</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>25</Day><Hour>9</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37227147</ArticleId><ArticleId IdType="pmc">PMC10269870</ArticleId><ArticleId IdType="doi">10.1128/spectrum.05352-22</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adedeji AO, Okonko IO, Adu FD. 2012. Comparative study of molecular and antigenic characterization for intratypic differentiation (ITD) of poliovirus strains. J Med Virol 84:1975–1979. doi:10.1002/jmv.23408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23408</ArticleId><ArticleId IdType="pubmed">23080505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn J, Joo CH, Seo I, Kim DH, Kim YK, Lee H. 2005. All CVB serotypes and clinical isolates induce irreversible cytopathic effects in primary cardiomyocytes. J Med Virol 75:290–294. doi:10.1002/jmv.20269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20269</ArticleId><ArticleId IdType="pubmed">15602738</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox DW, Khoo SK, Zhang G, Lindsay K, Keil AD, Knight G, Gern JE, Laing IA, Bizzintino J, Le Souëf PN. 2018. Rhinovirus is the most common virus and rhinovirus-C is the most common species in paediatric intensive care respiratory admissions. Eur Respir J 52:1800207. doi:10.1183/13993003.00207-2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00207-2018</ArticleId><ArticleId IdType="pmc">PMC6295450</ArticleId><ArticleId IdType="pubmed">29976655</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao B, Pietropaolo M, Atkinson M, Schatz D, Taylor D. 2010. Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching method. PLoS One 5:e11501. doi:10.1371/journal.pone.0011501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011501</ArticleId><ArticleId IdType="pmc">PMC2901386</ArticleId><ArticleId IdType="pubmed">20634976</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramley TJ, Lerner D, Sames M. 2002. Productivity losses related to the common cold. J Occup Environ Med 44:822–829. doi:10.1097/00043764-200209000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00043764-200209000-00004</ArticleId><ArticleId IdType="pubmed">12227674</ArticleId></ArticleIdList></Reference><Reference><Citation>Lugo D, Krogstad P. 2016. Enteroviruses in the early 21st century: new manifestations and challenges. Curr Opin Pediatr 28:107–113. doi:10.1097/MOP.0000000000000303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0000000000000303</ArticleId><ArticleId IdType="pmc">PMC4750492</ArticleId><ArticleId IdType="pubmed">26709690</ArticleId></ArticleIdList></Reference><Reference><Citation>Dingle TH, Badger GF, Jordan WS., Jr.. 1964. Illness in the home. A study of 25,000 illnesses in a group of Cleveland families. Cleveland: Western Reserve University Press.</Citation></Reference><Reference><Citation>Sinclair W, Omar M. 2022. Enterovirus. (Updated 2022 Aug 1). StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK562330/.</Citation><ArticleIdList><ArticleId IdType="pubmed">32966001</ArticleId></ArticleIdList></Reference><Reference><Citation>Poelman R, Schuffenecker I, van Leer-Buter C, Josset L, Niesters HGM, Lina B. study group E-EE-D. 2015. European surveillance for enterovirus D68 during the emerging North-American outbreak in 2014. J Clin Virol 71:1–9. doi:10.1016/j.jcv.2015.07.296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.07.296</ArticleId><ArticleId IdType="pubmed">26364237</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BA, Nix WA, Sheth M, Frace M, Oberste MS. 2014. Seven strains of enterovirus D68 detected in the United States during the 2014 severe respiratory disease outbreak. Genome Announc 2:e01201-14. doi:10.1128/genomeA.01201-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/genomeA.01201-14</ArticleId><ArticleId IdType="pmc">PMC4239358</ArticleId><ArticleId IdType="pubmed">25414503</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu Q, Zhou J, Cheng Y, Zhou Y, Liang L, Cui P, Xue Y, Wang L, Wang K, Wang H, Li P, Chen J, Li Y, Turtle L, Yu H. 2021. Kinetics of the neutralising antibody response in patients with hand, foot, and mouth disease caused by EV-A71: a longitudinal cohort study in Zhengzhou during 2017–2019. EBioMedicine 68:103398. doi:10.1016/j.ebiom.2021.103398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103398</ArticleId><ArticleId IdType="pmc">PMC8170117</ArticleId><ArticleId IdType="pubmed">34049245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma KC, Winn A, Moline HL, Scobie HM, Midgley CM, Kirking HL, Adjemian J, Hartnett KP, Johns D, Jones JM, Lopez A, Lu X, Perez A, Perrine CG, Rzucidlo AE, McMorrow ML, Silk BJ, Stein Z, Vega E, Hall AJ, Sahni LC, Avadhanula V, Halasa NB, Stewart LS, Klein EJ, Englund JA, Weinberg GA, York N, Szilagyi PG, Selvarangan R, Schuster JE, Williams JV, Michaels MG, Staat MA, Quigley C. New Vaccine Surveillance Network Collaborators. 2022. Increase in acute respiratory illnesses among children and adolescents associated with rhinoviruses and enteroviruses, including enterovirus D68 — United States, July–September 2022. MMWR Morb Mortal Wkly Rep 71:1265–1270. doi:10.15585/mmwr.mm7140e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7140e1</ArticleId><ArticleId IdType="pmc">PMC9541033</ArticleId><ArticleId IdType="pubmed">36201400</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau SKP, Yip CCY, Tsoi HW, Lee RA, So LY, Lau YL, Chan KH, Woo PCY, Yuen KY. 2007. Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children. J Clin Microbiol 45:3655–3664. doi:10.1128/JCM.01254-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01254-07</ArticleId><ArticleId IdType="pmc">PMC2168475</ArticleId><ArticleId IdType="pubmed">17804649</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon JW, Austin M, Onodera T, Notkins AL. 1979. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300:1173–1179. doi:10.1056/NEJM197905243002102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197905243002102</ArticleId><ArticleId IdType="pubmed">219345</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuelson A, Forsgren M, Johansson B, Wahren B, Sallberg M. 1994. Molecular basis for serological cross-reactivity between enteroviruses. Clin Diagn Lab Immunol 1:336–341. doi:10.1128/cdli.1.3.336-341.1994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cdli.1.3.336-341.1994</ArticleId><ArticleId IdType="pmc">PMC368258</ArticleId><ArticleId IdType="pubmed">7496972</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki J, Smith WA, Stone SR, Thomas WR, Hales BJ. 2013. Species-specific and cross-reactive IgG1 antibody binding to viral capsid protein 1 (VP1) antigens of human rhinovirus species A, B and C. PLoS One 8:e70552. doi:10.1371/journal.pone.0070552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0070552</ArticleId><ArticleId IdType="pmc">PMC3737412</ArticleId><ArticleId IdType="pubmed">23950960</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertens T, Pika U, Eggers HJ. 1983. Cross antigenicity among enteroviruses as revealed by immunoblot technique. Virology 129:431–442. doi:10.1016/0042-6822(83)90181-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(83)90181-2</ArticleId><ArticleId IdType="pubmed">6312682</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu GJ, Kula T, Xu Q, Li MZ, Vernon SD, Ndung'u T, Ruxrungtham K, Sanchez J, Brander C, Chung RT, O'Connor KC, Walker B, Larman HB, Elledge SJ. 2015. Comprehensive serological profiling of human populations using a synthetic human virome. Science 348:aaa0698. doi:10.1126/science.aaa0698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa0698</ArticleId><ArticleId IdType="pmc">PMC4844011</ArticleId><ArticleId IdType="pubmed">26045439</ArticleId></ArticleIdList></Reference><Reference><Citation>Saarinen NVV, Lehtonen J, Veijola R, Lempainen J, Knip M, Hyoty H, Laitinen OH, Hytonen VP. 2020. Multiplexed high-throughput serological assay for human enteroviruses. Microorganisms 8:1426. doi:10.3390/microorganisms8060963.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8060963</ArticleId><ArticleId IdType="pmc">PMC7355947</ArticleId><ArticleId IdType="pubmed">32604930</ArticleId></ArticleIdList></Reference><Reference><Citation>Saarinen NVV, Stone VM, Hankaniemi MM, Mazur MA, Vuorinen T, Flodstrom-Tullberg M, Hyoty H, Hytonen VP, Laitinen OH. 2020. Antibody responses against enterovirus proteases are potential markers for an acute infection. Viruses 12:78. doi:10.3390/v12010078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12010078</ArticleId><ArticleId IdType="pmc">PMC7020046</ArticleId><ArticleId IdType="pubmed">31936473</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubroth J, Brown F. 1995. Identification of native foot-and-mouth disease virus non-structural protein 2C as a serological indicator to differentiate infected from vaccinated livestock. Res Vet Sci 59:70–78. doi:10.1016/0034-5288(95)90034-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0034-5288(95)90034-9</ArticleId><ArticleId IdType="pubmed">8525090</ArticleId></ArticleIdList></Reference><Reference><Citation>Pou C, Nkulikiyimfura D, Henckel E, Olin A, Lakshmikanth T, Mikes J, Wang J, Chen Y, Bernhardsson AK, Gustafsson A, Bohlin K, Brodin P. 2019. The repertoire of maternal anti-viral antibodies in human newborns. Nat Med 25:591–596. doi:10.1038/s41591-019-0392-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0392-8</ArticleId><ArticleId IdType="pubmed">30886409</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon AK, Hollander GA, McMichael A. 2015. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci 282:20143085. doi:10.1098/rspb.2014.3085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rspb.2014.3085</ArticleId><ArticleId IdType="pmc">PMC4707740</ArticleId><ArticleId IdType="pubmed">26702035</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis T. 1960. On the doctrine of original antigenic sin. Proc Am Philos Soc 104:572–578.</Citation></Reference><Reference><Citation>Niespodziana K, Napora K, Cabauatan C, Focke-Tejkl M, Keller W, Niederberger V, Tsolia M, Christodoulou I, Papadopoulos NG, Valenta R. 2012. Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections. FASEB J 26:1001–1008. doi:10.1096/fj.11-193557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.11-193557</ArticleId><ArticleId IdType="pubmed">22121050</ArticleId></ArticleIdList></Reference><Reference><Citation>Saarinen NVV, Laiho JE, Richardson SJ, Zeissler M, Stone VM, Marjomaki V, Kantoluoto T, Horwitz MS, Sioofy-Khojine A, Honkimaa A, Hankaniemi MM, Flodstrom-Tullberg M, Hyoty H, Hytonen VP, Laitinen OH. 2018. A novel rat CVB1-VP1 monoclonal antibody 3A6 detects a broad range of enteroviruses. Sci Rep 8:33. doi:10.1038/s41598-017-18495-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-18495-4</ArticleId><ArticleId IdType="pmc">PMC5758616</ArticleId><ArticleId IdType="pubmed">29311608</ArticleId></ArticleIdList></Reference><Reference><Citation>Katze MG, Crowell RL. 1980. Immunological studies of the group B coxsackieviruses by the sandwich enzyme-linked immunosorbent assay (ELISA) and immunoprecipitation. J Gen Virol 50:357–367. doi:10.1099/0022-1317-50-2-357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-50-2-357</ArticleId><ArticleId IdType="pubmed">6161989</ArticleId></ArticleIdList></Reference><Reference><Citation>Katze MG, Crowell RL. 1980. Indirect enzyme-linked immunosorbent assay (ELISA) for the detection of Coxsackievirus group B antibodies. J Gen Virol 48:225–229. doi:10.1099/0022-1317-48-1-225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-48-1-225</ArticleId><ArticleId IdType="pubmed">6247437</ArticleId></ArticleIdList></Reference><Reference><Citation>Shingler K, Cifuente J, Ashley R, Makhov A, Conway J, Hafenstein S. 2015. The enterovirus 71 procapsid binds neutralizing antibodies and rescues virus infection in vitro. J Virol 89:1900–1908. doi:10.1128/JVI.03098-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03098-14</ArticleId><ArticleId IdType="pmc">PMC4300772</ArticleId><ArticleId IdType="pubmed">25428877</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, Subbarao K, Kent SJ, Triccas JA, Davenport MP. 2021. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med 27:1205–1211. doi:10.1038/s41591-021-01377-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01377-8</ArticleId><ArticleId IdType="pubmed">34002089</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajput C, Han M, Ishikawa T, Lei J, Goldsmith AM, Jazaeri S, Stroupe CC, Bentley JK, Hershenson MB. 2021. Rhinovirus C infection induces type 2 innate lymphoid cell expansion and eosinophilic airway inflammation. Front Immunol 12:649520. doi:10.3389/fimmu.2021.649520.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.649520</ArticleId><ArticleId IdType="pmc">PMC8100319</ArticleId><ArticleId IdType="pubmed">33968043</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone VM, Hankaniemi MM, Svedin E, Sioofy-Khojine A, Oikarinen S, Hyoty H, Laitinen OH, Hytonen VP, Flodstrom-Tullberg M. 2018. A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes. Diabetologia 61:476–481. doi:10.1007/s00125-017-4492-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-017-4492-z</ArticleId><ArticleId IdType="pmc">PMC6448957</ArticleId><ArticleId IdType="pubmed">29151123</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone VM, Hankaniemi MM, Laitinen OH, Sioofy-Khojine AB, Lin A, Lozano IMD, Mazur MA, Marjomaki V, Lore K, Hyoty H, Hytonen VP, Flodstrom-Tullberg M. 2020. A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates. Sci Adv 6:eaaz2433. doi:10.1126/sciadv.aaz2433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aaz2433</ArticleId><ArticleId IdType="pmc">PMC7202868</ArticleId><ArticleId IdType="pubmed">32494709</ArticleId></ArticleIdList></Reference><Reference><Citation>Hankaniemi MM, Stone VM, Sioofy-Khojine A-B, Heinimaki S, Marjomaki V, Hyoty H, Blazevic V, Laitinen OH, Flodstrom-Tullberg M, Hytonen VP. 2019. A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine. Vaccine 37:5962–5971. doi:10.1016/j.vaccine.2019.08.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.08.037</ArticleId><ArticleId IdType="pubmed">31471148</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Nguyen MT, Currier MG, Jenkins JB, Strobert EA, Kajon AE, Madan-Lala R, Bochkov YA, Gern JE, Roy K, Lu X, Erdman DD, Spearman P, Moore ML. 2016. A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques. Nat Commun 7:12838. doi:10.1038/ncomms12838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12838</ArticleId><ArticleId IdType="pmc">PMC5036149</ArticleId><ArticleId IdType="pubmed">27653379</ArticleId></ArticleIdList></Reference><Reference><Citation>Yee PTI, Poh CL. 2015. Development of novel vaccines against enterovirus-71. Viruses 8:1. doi:10.3390/v8010001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v8010001</ArticleId><ArticleId IdType="pmc">PMC4728561</ArticleId><ArticleId IdType="pubmed">26729152</ArticleId></ArticleIdList></Reference><Reference><Citation>Nix WA, Oberste MS, Pallansch MA. 2006. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol 44:2698–2704. doi:10.1128/JCM.00542-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00542-06</ArticleId><ArticleId IdType="pmc">PMC1594621</ArticleId><ArticleId IdType="pubmed">16891480</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray S, Steven RT, Green FM, Hook F, Taskinen B, Hytonen VP, Shard AG. 2015. Neutralized chimeric avidin binding at a reference biosensor surface. Langmuir 31:1921–1930. doi:10.1021/la503213f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/la503213f</ArticleId><ArticleId IdType="pubmed">25650821</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. 2022. R: a language and environment for statistical computing. 4.2.1. R Foundation for Statistical Computing, Vienna, Austria.</Citation></Reference><Reference><Citation>Wickham H. 2016. ggplot2: elegant graphics for data analysis. Springer-Verlag, New York.</Citation></Reference><Reference><Citation>Wickham H, François R, Henry L, Müller K. 2022. dplyr: a grammar of data manipulation. 1.0.10.</Citation></Reference><Reference><Citation>Wickham H. 2007. Reshaping data with the reshape package. J Stat Soft 21. doi:10.18637/jss.v021.i12.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v021.i12</ArticleId></ArticleIdList></Reference><Reference><Citation>Alboukadel K. 2020. ggpubr: “ggplot2” based publication ready plots. 0.4.0.</Citation></Reference><Reference><Citation>Schloerke B, Larmarange J, Briatte F, Marbach M, Thoen E, Elberg A, Crowley J. 2021. GGally: extension to “ggplot2.” 2.1.2.</Citation></Reference><Reference><Citation>Neuwirth E. 2022. RColorBrewer: ColorBrewer palettes. 1.1-3.</Citation></Reference><Reference><Citation>Rudis B, Gandy D. 2017. waffle: create waffle chart visualizations in R. 0.7.0.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>